en · de · es · fr · pt
cardarine-notes.peptides3626.com › Faq › Background And Research Context — Beginner to Advanced

Background And Research Context — Beginner to Advanced

By Editorial Desk · published 2025-07-14 · last reviewed 2025-08-15 · Faq

prohibited list comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2025-08-15. Numbers and descriptions here follow the published literature rather than marketing material.

Background and Research Context

PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.

In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.

Identity and Pharmacological Mechanism

The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.

Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.

Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.

Cardarine at a glance

PropertyValueNotes
CAS Registry Number317318-70-0Unique identifier for the compound.
Chemical classPPARδ agonistSynthetic ligand for peroxisome proliferator-activated receptor delta.
AppearanceWhite to off-white solidTypical form of research-grade material.
SolubilitySoluble in DMSO and ethanolPoorly soluble in water.
Typical storage-20°CRecommended for long-term storage of stock solutions.

Regulation and Detection

Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.

Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.

Related pages on this site

Detection, Stability, and Quality

Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.

Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.

Background from the literature

The systematic names and formulas given refer to hypothetical forms in which amino groups are unprotonated and carboxyl groups are undissociated. This convention is useful to avoid various nomenclatural problems but should not be taken to imply that these structures represent an appreciable fraction of the amino-acid molecules.

"Patent Pending". FBI: Most Wanted. Season 4. Episode 6. 15 November 2022. CBS. "Via Negativa". The X-Files. Season 8. Episode 7. 17 December 2000. Fox Broadcasting Company. "Getting Off". CSI: Crime Scene Investigation. Season 4. Episode 16. 26 February 2004. CBS. "Users". Law & Order: Special Victims Unit. Season 11. Episode 7. 4 November 2009. NBC. "Echoes". Nikita. Season 1. Episode 16. 24 February 2011. The CW Television Network. "One Last Time". Homeland (TV series). Season 3. Episode 9. 24 November 2013. Showtime. "Bon Voyage". Graceland (TV series). Season 3. Episode 7. 6 August 2015. USA Network.

==== Qualified small business stock gain exclusion ==== The Omnibus Budget Reconciliation Act of 1993 allowed noncorporate taxpayers who acquired qualified small business stock and held the stock for more than five years to exclude from capital gain recognition of up to $10 million or 10 times the taxpayer's basis in the stock, which ever was greater. In order for the stock to qualify, the issuing corporation's aggregate gross assets needed to be no more than $50 million immediately before or after the stock issuance. The OBBBA changed the requirement to hold the stock for at least five years. For qualified small business stock acquired after July 4, 2025, a 50% exclusion is available for stock held at least three years, a 75% exclusion is available for stock held for at least four years, and a 100% continues to be available for stock held for at least five years. The OBBBA also increased the exclusion's limit to $15 million or 10 times the taxpayer's basis in the stock, which ever was greater. The $15-million limit will be subject to annual inflation adjustments in 2027 and thereafter. In addition, the OBBBA now allows the issuing corporation to have an aggregate gross asset limitation of up to $75 million for stock issued after July 4, 2025. The $75-million limit will be subject to annual inflation adjustments in 2027 and thereafter.

== Background == By the mid-1790s, Humboldt had devoted himself wholly to scientific investigations. Despite being offered a promotion and an increase in pay, he resigned his position as a mining official in the Prussian civil service in order to embark on a journey that would “advance him scientifically.” To the Minister of Mines in Berlin Humboldt declared: "I am considering a complete change in my mode of life, and I intend to withdraw from any official position with the state." His health, he claimed, had suffered. All he had wanted was to prepare himself for a scientific expedition by a practical employment in the mines. "As I have a deep conviction that such an expedition is highly important for increasing our knowledge of geology and physical science, I am exceedingly eager to devote my energies immediately to this end. After his mother's death in 1796, Humboldt inherited the financial means to pursue independent explorations. He decided to go to Italy, where he wanted to spend a year to a year and a half researching volcanoes. From there, he wanted to travel via Paris to England, where he would board a ship to the West Indies. However, the political instability caused by Napoleon's Italian campaign in 1797 forced Humboldt to cancel his plans. In May 1798, Humboldt traveled to Paris, where he met the botanist Aimé Bonpland. After their attempt to travel to Egypt had once again failed due to Napoleon and his campaign there, the two decided to go to Madrid in December 1798.

=== Volatile acidity === While volatile acidity (VA) is usually measured in terms of acetic acid content, its sensory perception is a combination of acetic (vinegary aromas) and ethyl acetate (nail polish remover and model airplane glue aromas). High levels of VA can inhibit wine yeast and may lead to a sluggish or stuck fermentation. Several microbes can be a source for VA, including Acetobacter, Brettanomyces, and film yeast such as Candida, as well as LAB. However, while LAB usually only produce acetic acid, these other microbes often produce ethyl acetate, as well as acetic acid. Most wine-producing countries have laws regulating the amount volatile acidity permitted for wine available for sale and consumption. In the United States, the legal limit is 0.9 g/L for foreign wine exported to the United States, 1.2 g/L for white table wine, 1.4 g/L for red wine, 1.5 g/L for white dessert wine, and 1.7 g/L for red dessert wine. European Union wine regulations limit VA to 1.08 g/L for white table wines and 1.20 g/L for red table wines. Heterofermenting species of Oenococcus and Lactobacillus have the potential to produce high levels of acetic acid through the metabolism of glucose, though with most strains of O. oeni, the amount is usually only 0.1 to 0.2 g/L. Several species of Pediococcus can also produce acetic acid through other pathways. Wines starting out with a high pH levels (above 3.5) stand the greatest risk of excessive acetic acid production due to the more favorable conditions for Lactobacillus and Pediococcus species. L.

Sources: en.wikipedia.org

Reference notes

CK1δ is involved in different developmental pathways, among them Wingless (Wnt)-, Hedgehog (Hh)-, and Hippo (Hpo)-pathways. In the Wnt pathway, CK1δ can phosphorylate different factors of the pathway, among them Dishevelled (Dvl), Axin, APC, and β-catenin. CK1δ also negatively influences the stability of β-catenin, after its phosphorylation on Ser-45, which permits GSK3β-mediated further phosphorylations and subsequent degradation.

Unlike the related medication eplerenone, spironolactone is said to not be metabolized by CYP3A4. However, hepatic CYP3A4 is likely responsible for the 6β-hydroxylation of 7α-TMS into 6β-OH-7α-TMS. 7α-TMS may also be hydroxylated at the C3α and C3β positions. Spironolactone is dethioacetylated into canrenone. Finally, the C17 γ-lactone ring of spironolactone is hydrolyzed by the paraoxonase PON3. It was originally thought to be hydrolyzed by PON1, but this was due to contamination with PON3.

However, Ukrainian presidential advisor Mykhailo Podolyak said Kyiv had "nothing to do" with the attack and said Russian anti-Kremlin guerrilla groups were responsible. The Liberty of Russia Legion and the Russian Volunteer Corps (RVC) later claimed responsibility for the attack, with the Legion claiming to have taken the border town of Kozinka and reached Graivoron. Evacuations were ordered in nine villages and a counter-terrorist operation were ordered in the affected areas by the regional government, while the Russian military dispatched fighter jets and artillery to the scene. The Institute for the Study of War later assessed that two "all-Russian pro-Ukrainian" groups had crossed the border with tanks, armoured personnel carriers and other armoured vehicles. Attacks were also reported on offices of the Interior Ministry and the FSB in Belgorod city. Gladkov later said 13 civilians were injured, damage was recorded in 29 houses and three cars were damaged and electricity was lost in 14 settlements. The NATO Parliamentary Assembly issued a declaration recognizing Russian atrocities in Ukraine as "genocide" according to the head of the Ukrainian delegation Yehor Cherniev. He said that the declaration included support for an international tribunal for Russian war crimes, helping Ukraine win the war and a commitment to help restore the country's territories by implementing more sanctions.

== Other functions == Blood specimen test tubes, vacutainers, and capillary tubes that use the lithium salt of heparin (lithium heparin) as an anticoagulant are usually marked with green stickers and green tops. Heparin has the advantage over EDTA of not affecting levels of most ions. However, the concentration of ionized calcium may be decreased if the concentration of heparin in the blood specimen is too high. Heparin can interfere with some immunoassays, however. As lithium heparin is usually used, a person's lithium levels cannot be obtained from these tubes; for this purpose, royal-blue-topped (and dark green-topped) vacutainers containing sodium heparin are used. Heparin-coated blood oxygenators are available for use in heart-lung machines. Among other things, these specialized oxygenators are thought to improve overall biocompatibility and host homeostasis by providing characteristics similar to those of native endothelium. The DNA binding sites on RNA polymerase can be occupied by heparin, preventing the polymerase from binding to promoter DNA. This property is exploited in a range of molecular biological assays. Common diagnostic procedures require PCR amplification of a patient's DNA, which is easily extracted from white blood cells treated with heparin. This poses a potential problem, since heparin may be extracted along with the DNA, and it has been found to interfere with the PCR reaction at levels as low as 0.002 U in a 50 μL reaction mixture. Heparin has been used as a chromatography resin, acting as both an affinity ligand and an ion exchanger.

Sources: en.wikipedia.org

Reference notes

An artificial organ is an engineered device that can be extra corporeal or implanted to support impaired or failing organ systems. Bioartificial organs are typically created with the intent to restore critical biological functions like in the replacement of diseased hearts and lungs, or provide drastic quality of life improvements like in the use of engineered skin on burn victims. While some examples of bioartificial organs are still in the research stage of development due to the limitations involved with creating functional organs, others are currently being used in clinical settings experimentally and commercially.

The Mind in Consider Phlebas is also described as having internal power sources which function as back-up shield generators and space propulsion, and seeing the rational, safety-conscious thinking of Minds, it would be reasonable to assume that all Minds have such features, as well as a complement of drones and other remote sensors as also described. Other equipment available to them spans the whole range of the Culture's technological capabilities and its practically limitless resources. However, this equipment would more correctly be considered emplaced in the ship or orbital that the Mind is controlling, rather than being part of the Mind itself.

Neonatal hyperbilirubinemia, where the newborn's liver is not able to properly process the bilirubin causing jaundice Hepatocellular disease Viral infections (hepatitis A, B, and C) Chronic alcohol use Autoimmune disorders Genetic syndromes: Gilbert's syndrome – a genetic disorder of bilirubin metabolism that can result in mild jaundice, found in about 5% of the population Rotor syndrome: non-itching jaundice, with rise of bilirubin in the patient's serum, mainly of the conjugated type Dubin–Johnson syndrome Crigler–Najjar syndrome Pharmaceutical drugs (especially antipsychotic, some sex hormones, and a wide range of other drugs) Sulfonamides are contraindicated in infants less than 2 months old (exception when used with pyrimethamine in treating toxoplasmosis) as they increase unconjugated bilirubin leading to kernicterus. Drugs such as protease inhibitors like Indinavir can also cause disorders of bilirubin metabolism by competitively inhibiting the UGT1A1 enzyme. Post-hepatic causes are associated with elevated levels of conjugated bilirubin. These include:

Enzymes are crucial to metabolism because they allow organisms to drive reactions that require energy and will not occur by themselves, by coupling them to spontaneous reactions that release energy. Enzymes act as catalysts—they allow a reaction to proceed more rapidly—and they also allow the regulation of the rate of a metabolic reaction, for example, in response to changes in the cell's environment or to signals from other cells. The metabolic system of a particular organism determines which substances it will find nutritious and which poisonous. For example, some prokaryotes use hydrogen sulfide (H₂S) as a nutrient, yet this gas is poisonous to some animals. Since hydrogen sulfide is a gasotransmitter, certain mammals including humans produce H₂S naturally in very small concentrations where it serves vital signaling and regulatory functions. The basal metabolic rate of an organism is the measure of the amount of energy consumed by all of these chemical reactions. A notable feature of metabolism is the similarity of the basic metabolic pathways among vastly different species. For example, the set of carboxylic acids that are best known as the intermediates in the citric acid cycle are present in all known organisms, being found in species as diverse as the unicellular bacterium Escherichia coli (E. coli) and huge multicellular organisms like elephants. These similarities in metabolic pathways are likely due to their early appearance in evolutionary history, and their retention is likely due to their efficacy.

Some symptoms of an overdose typically include sluggishness, incoordination, difficulty in thinking, slowness of speech, faulty judgement, drowsiness, shallow breathing, staggering, and, in severe cases, coma or death. The lethal dosage of barbiturates varies greatly with tolerance and from one individual to another. The lethal dose is highly variable among different members of the class, with superpotent barbiturates such as pentobarbital being potentially fatal in considerably lower doses than the low-potency barbiturates such as butalbital. Even in inpatient settings, the development of tolerance is still a problem, as dangerous and unpleasant withdrawal symptoms can result when the drug is stopped after dependence has developed. Tolerance to the anxiolytic and sedative effects of barbiturates tends to develop faster than tolerance to their effects on smooth muscle, respiration, and heart rate, making them generally unsuitable for a long time psychiatric use. Tolerance to the anticonvulsant effects tends to correlate more with tolerance to physiological effects, however, meaning that they are still a viable option for long-term epilepsy treatment. Barbiturates in overdose with other CNS (central nervous system) depressants (e.g. alcohol, opiates, benzodiazepines) are even more dangerous owing to additive CNS and respiratory depressant effects. In the case of benzodiazepines, not only do they have additive effects, barbiturates also increase the binding affinity of the benzodiazepine binding site, leading to exaggerated benzodiazepine effects. (ex.

Sources: en.wikipedia.org

Frequently asked questions

What is cardarine?

Cardarine is a common name for GW501516, a synthetic PPARδ agonist developed for research. It has not been approved as a medication in any country. It is classified as an unapproved drug and a prohibited substance in sport.

Is cardarine a steroid?

No. Cardarine is not an anabolic steroid; it belongs to a different chemical class that targets PPARδ. Steroids act primarily through androgen receptors, while cardarine acts through a nuclear receptor involved in metabolism.

What did animal studies find?

Some rodent studies reported increased endurance and changes in fat metabolism after cardarine exposure. Long-term studies in animals also raised concerns about cancer in certain tissues. Human trial data are limited, so these findings cannot be directly translated to people.

What is cardarine?

Cardarine is a common name for GW501516, a synthetic PPARδ agonist. It is not a steroid or a selective androgen receptor modulator. It was developed and studied as a research compound for metabolic pathways.

Network